08:27 AM EDT, 03/12/2024 (MT Newswires) -- Enfusion ( ENFN ) reported Q4 earnings Tuesday of $0.01 per diluted share, unchanged from a year earlier.

Four analysts polled by Capital IQ expected $0.03.

Revenue for the quarter ended Dec. 31 was $46.5 million, up from $40.5 million a year earlier.

Analysts surveyed by Capital IQ expected $45.1 million.

For the full year 2024, the company said it expects revenue of $200 million to $210 million. Analysts polled by Capital IQ are expecting $202.3 million.

Shares of the company were up 5.6% in recent Tuesday premarket activity.

Price: 9, Change: +0.48, Percent Change: +5.63